Risk Factors Update Summary
- Added risks related to insufficient funds for debt servicing, potential stock dilution, and adverse actions.
- Increased regulatory challenges and potential penalties due to non-compliance with global regulations.
- Expanded product approval risks with FDA warnings and clearances for new product indications.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=719135&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.